Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-974-4 | CAS number: 68647-86-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The acute inhalative toxicity of the Read-Across substance charcoal (Probe 2: C-Fix=80.5%) was investigated in a study in rats that was performed according to OECD guideline no. 403, EU method B.2 and the US EPA Health Effects Test guideline OPPTS 870.1300, Acute Inhalation Toxicity, as per August 1998.
The acute oral toxicity of coconut shell charcoal was investigated in a study in rats that was performed according to OECD guideline no. 423.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute toxicity: Inhalative route
This test was not conducted with coconut shell charcoal but due to the Read-Across approach the test results for “Charcoal” can be used:
In this study, a group of 10 Wistar Crl: (WI) BR rats (5 males and 5 females) was exposed to an aerosol atmosphere. The animals were exposed for 4 h using a nose-only exposure system, followed by a 14-d observation period.The mean achieved concentration of charcoal in the exposure was 4.968 mg/L (standard deviation: 3.624 mg/L; nominal concentration: 18.2 mg/L).The characteristics of the test atmosphere were as follows: Mean mass median aerodynamic diameter (MMAD) (mm): 3.52 µm; geometric standard deviation: 2.46; inhalable fraction (< 4 µm): 52.3%
No death occurred in the test animals.In males, test item related clinical signs were found between the third hour of inhalation exposure and first hour of observation period. All animals were symptom –free on first day of observation period.In females animals, test item related clinical signs were found between the third hour of inhalation exposure and first hour of observation period. All female animals were symptom–free from first day of observation period.The clinical signs represented the decreased activity and general reaction and dyspnoea.In both genders, body weight loss was observable on the day of inhalation exposure. In both sexes, a compensation of body weight loss was found from third day of observation period.On basis of body weight and body weight gain data, there was no notable test item effect observable in the exposed animals.
In conclusion, a single 4-h nose-only exposure to charcoal sample Probe 2 to CRL: (WI) BR rat followed by a 14-day observation period at a dose level 5 mg/L was not associated with mortality or any test item-related toxicological findings on the male and female animals.
Accordingly, the acute inhalation median lethal concentration (4-h LC50) of charcoal rats was therefore considered to be greater than 4.97 mg/L.
Acute toxicity: Oral route
According to REACH Regulation (EC) No. 1907/2006, Annex IX, 7.1.5, column 2, a study on the acute toxicity after oral administration is not required as acute toxicity upon inhalation has been investigated.As the study on acute toxicity upon inhalation was only performed with the Read-Across substance charcoal the testing of the acute toxicity after oral administration was performed.
In this study two groups, each consisting of three female RccHan:WIST (SPF) rats, were treated with coconut shell charcoal by single oral gavage administration at a dosage of 2000 mg/kg body weight. The test item was formulated in PEG 300 at a concentration of 0.2 g/ml and administered at a dosing volume of 10 ml/kg.
The animals were examined daily during the acclimatization period and mortality, viability and clinical sign were recorded. All animals were examined for clinical signs before treatment, within the first 30 minutes and approximately 1, 2, 3 and 5 hours after treatment on day 1 and once daily during test days 2-15. Mortality/viability was recorded before treatment, within the first 30 minutes and approximately 1, 2, 3 and 5 hours after administration on test day 1 (with the clinical signs) and twice daily during days 2-15. Body weights were recorded on day 1 (prior to administration) and on days 8 and 15. All animals were necropsied and examined macroscopically.
No intercurrent deaths occurred during the course of the study.
All animals excreted feces stained in black one day after the administration (test day 2). No other clinical signs were observed during the course of the study.
One animal showed a slight loss of body weight (-1,7%) from test day 8 to day 15. Otherwise, the body weight of the animals was within the range commonly recorded for this strain and age.
No macroscopic findings were recorded at necropsy.
The median lethal dose of coconut shell charcoal after single oral administration to female rats, observed over a period of 14 days, is:
LD50(female rat): >2000 mg/kg body weight.
Acute toxicity: Dermal route
Justification for classification or non-classification
Based on the results of the acute inhalative toxicity studies in rats (for the Read-Across substance carcoal), coconut shell charcoal is not classified for acute inhalation toxicity as specified in the current EU-CLP regulation.
Based upon the referred classification criteria (Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008), coconut shell charcoal is not classified with respect due acute oral toxicity in the rat.
A classification of coconut shell charcoal for acute dermal toxicity is not possible, as no studies with coconut shell charcoal were conducted for these endpoints. However, it is reasonable to assume that coconut shell charcoal is virtually non-toxic when applied to the skin, since it is well known that coconut shell charcoal is not systemically absorbed through the skin and also does not induce any overt local effects in the skin.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Questo sito web si avvale di cookie affinché possiate usufruire della migliore esperienza sui nostri siti web.